Showing results (41-50 of 1,401) with videos related to
Sort By:
Pageof 141
Endocrinology and Metabolism Clinics of North America|September 1, 1994
Cushing's syndrome and the nodular adrenal glandM H Samuels, D L LoriauxAnnual Review of Medicine|January 1, 1989
Corticotropin-releasing hormone: clinical applicationsL K Nieman, D L LoriauxJournal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Epi-inositol is biochemically active in reversing lithium effects on cytidine monophosphorylphosphatidate (CMP-PA). Short communicationM H Richards, R H BelmakerDepression and Anxiety|December 29, 2000
Animal models of the mechanisms of action of repetitive transcranial magnetic stimulation (RTMS): comparisons with electroconvulsive shock (ECS)S H Lisanby, R H BelmakerBipolar Disorders|March 17, 2001
The high affinity inositol transport system--implications for the pathophysiology and treatment of bipolar disorderD van Calker, R H BelmakerNeuropharmacology|February 1, 1987
Effects of lithium in vitro and ex vivo on components of the adenylate cyclase system in membranes from the cerebral cortex of the ratM E Newman, R H BelmakerThe American Journal of Psychiatry|April 28, 2000
Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patientsN Kozlovsky, R H Belmaker, G AgamEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 15, 2002
GSK-3 and the neurodevelopmental hypothesis of schizophreniaNitsan Kozlovsky, R H Belmaker, Galila AgamCurrent Pharmaceutical Design|July 9, 2011
The possible involvement of glycogen synthase kinase-3 (GSK-3) in diabetes, cancer and central nervous system diseasesS Amar, R H Belmaker, G AgamEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 1, 1996
Phorbol ester intracerebroventricularly induces a behavioral hypoactivity that is not affected by chronic or acute lithiumY Patishi, Y Bersudsky, R H BelmakerPageof 141